Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
Sales | 0 | 0 | 4 | 2 | 0 |
Gross Profit | 0 | 0 | 4 | 2 | 0 |
Operating Expenses | 100 | 240 | 340 | 460 | 420 |
Operating Income | -100 | -240 | -336 | -458 | -420 |
Interest Expense | 20 | 10 | 10 | 40 | 50 |
Other Income | -20 | 0 | 6 | 228 | 10 |
Pre-tax Income | -140 | -250 | -340 | -270 | -460 |
Income Tax | 60 | 0 | 0 | 0 | 0 |
Net Income Continuous | -200 | -250 | -343 | -277 | -460 |
Net Income | $-200 | $-250 | $-343 | $-277 | $-460 |
EPS Basic Total Ops | N/A | N/A | -8,589.12 | -8,589.12 | -17,178.23 |
EPS Basic Continuous Ops | N/A | N/A | -8,589.12 | -8,589.12 | -17,178.23 |
EPS Diluted Total Ops | N/A | N/A | -8,589.12 | -8,589.12 | -17,178.23 |
EPS Diluted Continuous Ops | N/A | N/A | -8,589.12 | -8,589.12 | -17,178.23 |
EBITDA(a) | $-290 | $-30 | $-326 | $-480 | $-410 |